| Original language | English |
|---|---|
| Pages (from-to) | e37-e50 |
| Journal | Journal of Nuclear Cardiology |
| Volume | 15 |
| Issue number | 6 |
| DOIs | |
| State | Published - 2008 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Nuclear Cardiology, Vol. 15, No. 6, 2008, p. e37-e50.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Ninth Nuclear Cardiology Invitational Conference, Annapolis, Maryland, 2008
AU - Garcia, Ernest V.
AU - Gropler, Robert J.
N1 - Funding Information: From June 28 to July 1, 2008, a group of invited leaders in nuclear cardiology and related disciplines met in Annapolis, Maryland, to examine the current state of nuclear cardiology and to determine where our field needs to go to achieve its full potential of using the tracer principle to detect, assess, and manage cardiac disease. More importantly, the main goal of the meeting was to develop recommendations that would provide a roadmap to focus the efforts of professional societies, clinicians, scientists, government agencies, and industry to clinically manage patients with cardiac disease. A longstanding feature of this conference has been the invitation of experts outside of the field to broaden our perspective. This year, R. Wayne Alexander, MD, PhD, Chairman of Medicine at Emory University, and Michael Lauer, MD, Director of the Division of Prevention and Population Sciences at the National Heart, Lung, and Blood Institute, provided keynote lectures to stimulate all attendees. The conference was funded, coordinated, and superbly staffed by the Nuclear Cardiology Foundation. Funding Information: We thank the Nuclear Cardiology Foundation and all who participated in this event and hope that the recommendations in this document will spur all stakeholders to work together at this opportune time to make our full potential a reality. We also gratefully acknowledge the support of this conference and this document, which were made possible in part by grants from Astellas Pharma US, Inc; Bracco Diagnostics Inc; Capintec, Inc; Covidien; Digirad; GE Healthcare; INVIA Medical Imaging Solutions; King Pharmaceuticals; Lantheus Medical Imaging; MDS Nordion; Molecular Insight Pharmaceuticals; and Philips Medical Systems.
PY - 2008
Y1 - 2008
UR - https://www.scopus.com/pages/publications/54449097119
U2 - 10.1016/j.nuclcard.2008.08.006
DO - 10.1016/j.nuclcard.2008.08.006
M3 - Article
C2 - 18984445
AN - SCOPUS:54449097119
SN - 1071-3581
VL - 15
SP - e37-e50
JO - Journal of Nuclear Cardiology
JF - Journal of Nuclear Cardiology
IS - 6
ER -